Squarepoint Ops LLC Arbutus Biopharma Corp Transaction History

Squarepoint Ops LLC

$59.6 Billion
Q2 2024

A detailed history of Squarepoint Ops LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 1,445,000 shares of ABUS stock, worth $5.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,445,000

Previous 1,445,000 -0.0%

Holding current value

$5.56 Million

Previous $3.73 Million 19.77%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.91 - $2.85 $26,071 - $38,902	13,650 New	13,650 $31,000
Q1 2022 May 16, 2022	SELL	$2.42 - $3.98 $96,833 - $159,255	-40,014 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $124,443 - $184,464	40,014 New	40,014 $156,000
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.51 $74,700 - $104,878	-29,880 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.14 - $4.84 $93,823 - $144,619	29,880 New	29,880 $100,000
Q3 2020 Nov 16, 2020	SELL	$1.75 - $6.2 $563,893 - $2 Million	-322,225 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.91 - $2.36 $254,783 - $660,757	279,982 Added 662.79%	322,225 $586,000
Q1 2020 May 15, 2020	BUY	$1.01 - $3.42 $42,665 - $144,471	42,243 New	42,243 $43,000
Q3 2019 Nov 14, 2019	SELL	$1.34 - $2.4 $88,236 - $158,035	-65,848 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.46 - $4.44 $96,138 - $292,365	65,848 New	65,848 $137,000
Q2 2018 Aug 14, 2018	SELL	$5.0 - $7.35 $66,500 - $97,755	-13,300 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$4.4 - $6.05 $1,320 - $1,815	-300 Reduced 2.21%	13,300 $67,000
Q4 2017 Feb 14, 2018	BUY	$4.45 - $7.7 $14,685 - $25,410	3,300 Added 32.04%	13,600 $69,000
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $35,020 - $72,100	10,300	10,300 $64,000

Others Institutions Holding ABUS

# of Institutions

138

Shares Held

95.5M

Call Options Held

3.44M

Put Options Held

377K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Arbutus Biopharma Corp Transaction History